- Home
- WBX vs TENX Comparison
WBX vs TENX Comparison
Compare WBX & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WBX | TENX |
|---|---|---|
| Founded | 2015 | 1967 |
| Country | Spain | United States |
| Employees | 696 | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.6M | 56.2M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | WBX | TENX |
|---|---|---|
| Price | $3.23 | $15.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $4.75 | ★ $29.67 |
| AVG Volume (30 Days) | 19.0K | ★ 476.2K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.10 | N/A |
| Revenue Next Year | $94.11 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.23 | $5.34 |
| 52 Week High | $7.83 | $18.38 |
Technical Indicators
Market Signals| Indicator | WBX | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 61.85 | 56.47 |
| Support Level | $2.84 | $12.84 |
| Resistance Level | $3.26 | $16.61 |
| Average True Range (ATR) | 0.21 | 0.94 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 91.86 | 72.87 |
Price Performance
Historical ComparisonAbout WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.